Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Bushen Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily utilized as an adjuvant therapy for patients with colorectal cancer undergoing chemotherapy. The formula is designed according to the TCM principles of "Jianpi" (strengthening the Spleen) and "Bushen" (tonifying the Kidney), which are considered essential for maintaining digestive health and hematopoietic function. It is clinically investigated for its ability to reduce chemotherapy-induced myelosuppression, specifically by mitigating the decline of white blood cells, hemoglobin, and platelets. Additionally, it is used to improve the quality of life, enhance immune function, and potentially reduce the risk of postoperative recurrence in high-risk colorectal cancer populations. The decoction is typically administered orally in combination with standard Western chemotherapy regimens such as FOLFOX or XELOX.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Bushen Decoction.